相关实验视频
Updated: Jan 9, 2026

14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
8.2K
用ICS/LABA治疗的波兰慢性阻塞性肺病患者的恶化和肺功能:两年前性观察性研究
Piotr W Boros1, Rafał Pawliczak2, Tomasz Dębowski3
1Lung Pathophysiology Department, Institute of Tuberculosis and Lung Diseases, Plocka 26, 01-138 Warsaw, Poland.
Journal of clinical medicine
|December 11, 2025
概括
慢性阻塞性肺病 (COPD) 的吸入性皮质类固醇/长效β-agonist (ICS/LABA) 治疗在两年内显示出稳定的肺功能. 症状和并发症,而不是肺功能,在波兰患者中预测了恶化.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 流行病学 流行病学
背景情况:
- 慢性阻塞性肺病 (COPD) 的管理包括吸入性皮质类固醇/长效β-激动剂 (ICS/LABA) 治疗.
- 了解恶化频率和现实环境中的影响因素对于优化患者护理至关重要.
- 之前的研究集中在特定的干预措施,但现实世界关于波兰ICS/LABA使用的数据有限.
研究的目的:
- 评估波兰接受ICS/LABA治疗的患者中COPD恶化的频率.
- 调查恶化和肺功能参数之间的关联.
- 在常规临床实践中识别与COPD恶化相关的因素.
主要方法:
- 对COPD患者进行至少6个月的ICS/LABA前性观察研究.
- 随访时间2年,后续访问4次.
- 数据收集包括肺功能测试 (FEV1,%预期,z分数),恶化史,症状 (mMRC,CAT) 和并发症.
主要成果:
- 大多数患者 (约. 80%的人在每次访问时都报告了显著的症状 (mMRC ≥2,CAT ≥10).
- 76.5%的患者在研究前一年至少经历过一次恶化.
- 并发症 (OR = 1.556) 和较高的mMRC得分 (OR = 2.656) 独立地与COPD恶化有关.
结论:
- 肺功能和患者报告的结果在2年的研究期间保持稳定.
- 呼吸不全 (mMRC) 的症状和并发症的存在是COPD恶化的关键预测因素.
- 单独的肺功能下降与这种ICS/LABA治疗队列中的恶化风险没有显著关联.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K

